1 Market Overview of Adenovirus Vector Vaccine 1.1 Adenovirus Vector Vaccine Market Overview 1.1.1 Adenovirus Vector Vaccine Product Scope 1.1.2 Adenovirus Vector Vaccine Market Status and Outlook 1.2 Global Adenovirus Vector Vaccine Market Size Overview by Region 2016 VS 2021VS 2027 1.3 Global Adenovirus Vector Vaccine Market Size by Region (2016-2027) 1.4 Global Adenovirus Vector Vaccine Historic Market Size by Region (2016-2021) 1.5 Global Adenovirus Vector Vaccine Market Size Forecast by Region (2022-2027) 1.6 Key Regions, Adenovirus Vector Vaccine Market Size (2016-2027) 1.6.1 North America Adenovirus Vector Vaccine Market Size (2016-2027) 1.6.2 Europe Adenovirus Vector Vaccine Market Size (2016-2027) 1.6.3 Asia-Pacific Adenovirus Vector Vaccine Market Size (2016-2027) 1.6.4 Latin America Adenovirus Vector Vaccine Market Size (2016-2027) 1.6.5 Middle East & Africa Adenovirus Vector Vaccine Market Size (2016-2027) 2 Adenovirus Vector Vaccine Market Overview by Type 2.1 Global Adenovirus Vector Vaccine Market Size by Type: 2016 VS 2021 VS 2027 2.2 Global Adenovirus Vector Vaccine Historic Market Size by Type (2016-2021) 2.3 Global Adenovirus Vector Vaccine Forecasted Market Size by Type (2022-2027) 2.4 Being Developed 2.5 Preclinical 2.6 Clinical I 2.7 Clinical II 3 Adenovirus Vector Vaccine Market Overview by Application 3.1 Global Adenovirus Vector Vaccine Market Size by Application: 2016 VS 2021 VS 2027 3.2 Global Adenovirus Vector Vaccine Historic Market Size by Application (2016-2021) 3.3 Global Adenovirus Vector Vaccine Forecasted Market Size by Application (2022-2027) 3.4 Pharmaceutical And Biotechnology Companies 3.5 Hospital 3.6 Academic And Research Organizations 3.7 Other 4 Adenovirus Vector Vaccine Competition Analysis by Players 4.1 Global Adenovirus Vector Vaccine Market Size by Players (2016-2021) 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Adenovirus Vector Vaccine as of 2020) 4.3 Date of Key Players Enter into Adenovirus Vector Vaccine Market 4.4 Global Top Players Adenovirus Vector Vaccine Headquarters and Area Served 4.5 Key Players Adenovirus Vector Vaccine Product Solution and Service 4.6 Competitive Status 4.6.1 Adenovirus Vector Vaccine Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Johnson & Johnson 5.1.1 Johnson & Johnson Profile 5.1.2 Johnson & Johnson Main Business 5.1.3 Johnson & Johnson Adenovirus Vector Vaccine Products, Services and Solutions 5.1.4 Johnson & Johnson Adenovirus Vector Vaccine Revenue (US$ Million) & (2016-2021) 5.1.5 Johnson & Johnson Recent Developments 5.2 CanSino Biologics 5.2.1 CanSino Biologics Profile 5.2.2 CanSino Biologics Main Business 5.2.3 CanSino Biologics Adenovirus Vector Vaccine Products, Services and Solutions 5.2.4 CanSino Biologics Adenovirus Vector Vaccine Revenue (US$ Million) & (2016-2021) 5.2.5 CanSino Biologics Recent Developments 5.3 Greffex 5.5.1 Greffex Profile 5.3.2 Greffex Main Business 5.3.3 Greffex Adenovirus Vector Vaccine Products, Services and Solutions 5.3.4 Greffex Adenovirus Vector Vaccine Revenue (US$ Million) & (2016-2021) 5.3.5 BravoBio Recent Developments 5.4 BravoBio 5.4.1 BravoBio Profile 5.4.2 BravoBio Main Business 5.4.3 BravoBio Adenovirus Vector Vaccine Products, Services and Solutions 5.4.4 BravoBio Adenovirus Vector Vaccine Revenue (US$ Million) & (2016-2021) 5.4.5 BravoBio Recent Developments 5.5 Altimmune 5.5.1 Altimmune Profile 5.5.2 Altimmune Main Business 5.5.3 Altimmune Adenovirus Vector Vaccine Products, Services and Solutions 5.5.4 Altimmune Adenovirus Vector Vaccine Revenue (US$ Million) & (2016-2021) 5.5.5 Altimmune Recent Developments ... 6 North America 6.1 North America Adenovirus Vector Vaccine Market Size by Country (2016-2027) 6.2 United States 6.3 Canada 7 Europe 7.1 Europe Adenovirus Vector Vaccine Market Size by Country (2016-2027) 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific Adenovirus Vector Vaccine Market Size by Region (2016-2027) 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America Adenovirus Vector Vaccine Market Size by Country (2016-2027) 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa Adenovirus Vector Vaccine Market Size by Country (2016-2027) 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 Adenovirus Vector Vaccine Market Dynamics 11.1 Adenovirus Vector Vaccine Industry Trends 11.2 Adenovirus Vector Vaccine Market Drivers 11.3 Adenovirus Vector Vaccine Market Challenges 11.4 Adenovirus Vector Vaccine Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market Adenovirus Vector Vaccine Market Size (US$ Million) Comparison by Region 2016 VS 2021 VS 2027 Table 2. Global Adenovirus Vector Vaccine Market Size by Region (2016-2021) & (US$ Million) Table 3. Global Adenovirus Vector Vaccine Market Size Share by Region (2016-2021) Table 4. Global Adenovirus Vector Vaccine Forecasted Market Size by Region (2022-2027) & (US$ Million) Table 5. Global Adenovirus Vector Vaccine Forecasted Market Size Share by Region (2022-2027) Table 6. Global Adenovirus Vector Vaccine Market Size (US$ Million) by Type: 2016 VS 2021 VS 2027 Table 7. Global Adenovirus Vector Vaccine Market Size by Type (2016-2021) & (US$ Million) Table 8. Global Adenovirus Vector Vaccine Revenue Market Share by Type (2016-2021) Table 9. Global Adenovirus Vector Vaccine Forecasted Market Size by Type (2022-2027) & (US$ Million) Table 10. Global Adenovirus Vector Vaccine Revenue Market Share by Type (2022-2027) Table 11. Global Adenovirus Vector Vaccine Market Size (US$ Million) by Application: 2016 VS 2021 VS 2027 Table 12. Global Adenovirus Vector Vaccine Market Size by Application (2016-2021) & (US$ Million) Table 13. Global Adenovirus Vector Vaccine Revenue Market Share by Application (2016-2021) Table 14. Global Adenovirus Vector Vaccine Forecasted Market Size by Application (2022-2027) & (US$ Million) Table 15. Global Adenovirus Vector Vaccine Revenue Market Share by Application (2022-2027) Table 16. Global Adenovirus Vector Vaccine Revenue (US$ Million) by Players (2016-2021) Table 17. Global Adenovirus Vector Vaccine Revenue Market Share by Players (2016-2021) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Adenovirus Vector Vaccine as of 2020) Table 19. Date of Key Manufacturers Enter into Adenovirus Vector Vaccine Market Table 20. Global Adenovirus Vector Vaccine Top Players Headquarters and Area Served Table 21. Adenovirus Vector Vaccine Product Solution and Service Table 22. Global Adenovirus Vector Vaccine Players Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Johnson & Johnson Basic Information List Table 25. Johnson & Johnson Description and Business Overview Table 26. Johnson & Johnson Adenovirus Vector Vaccine Products, Services and Solutions Table 27. Revenue (US$ Million) in Adenovirus Vector Vaccine Business of Johnson & Johnson (2016-2021) Table 28. Johnson & Johnson Recent Developments Table 29. CanSino Biologics Basic Information List Table 30. CanSino Biologics Description and Business Overview Table 31. CanSino Biologics Adenovirus Vector Vaccine Products, Services and Solutions Table 32. Revenue (US$ Million) in Adenovirus Vector Vaccine Business of CanSino Biologics (2016-2021) Table 33. CanSino Biologics Recent Developments Table 34. Greffex Basic Information List Table 35. Greffex Description and Business Overview Table 36. Greffex Adenovirus Vector Vaccine Products, Services and Solutions Table 37. Revenue (US$ Million) in Adenovirus Vector Vaccine Business of Greffex (2016-2021) Table 38. Greffex Recent Developments Table 39. BravoBio Basic Information List Table 40. BravoBio Description and Business Overview Table 41. BravoBio Adenovirus Vector Vaccine Products, Services and Solutions Table 42. Revenue (US$ Million) in Adenovirus Vector Vaccine Business of BravoBio (2016-2021) Table 43. BravoBio Recent Developments Table 44. Altimmune Basic Information List Table 45. Altimmune Description and Business Overview Table 46. Altimmune Adenovirus Vector Vaccine Products, Services and Solutions Table 47. Revenue (US$ Million) in Adenovirus Vector Vaccine Business of Altimmune (2016-2021) Table 48. Altimmune Recent Developments Table 49. North America Adenovirus Vector Vaccine Market Size by Country (2016-2021) & (US$ Million) Table 50. North America Adenovirus Vector Vaccine Market Size by Country (2022-2027) & (US$ Million) Table 51. Europe Adenovirus Vector Vaccine Market Size by Country (2016-2021) & (US$ Million) Table 52. Europe Adenovirus Vector Vaccine Market Size by Country (2022-2027) & (US$ Million) Table 53. Asia-Pacific Adenovirus Vector Vaccine Market Size by Region (2016-2021) & (US$ Million) Table 54. Asia-Pacific Adenovirus Vector Vaccine Market Size by Region (2022-2027) & (US$ Million) Table 55. Asia-Pacific Adenovirus Vector Vaccine Market Share by Region (2016-2021) Table 56. Asia-Pacific Adenovirus Vector Vaccine Market Share by Region (2022-2027) Table 57. Latin America Adenovirus Vector Vaccine Market Size by Country (2016-2021) & (US$ Million) Table 58. Latin America Adenovirus Vector Vaccine Market Size by Country (2022-2027) & (US$ Million) Table 59. Middle East & Africa Adenovirus Vector Vaccine Market Size by Players (2016-2021) & (US$ Million) Table 60. Middle East & Africa Adenovirus Vector Vaccine Market Size by Country (2022-2027) & (US$ Million) Table 61. Adenovirus Vector Vaccine Market Trends Table 62. Adenovirus Vector Vaccine Market Drivers Table 63. Adenovirus Vector Vaccine Market Challenges Table 64. Adenovirus Vector Vaccine Market Restraints Table 65. Research Programs/Design for This Report Table 66. Key Data Information from Secondary Sources Table 67. Key Data Information from Primary Sources List of Figures Figure 1. Global Adenovirus Vector Vaccine Market Size Year-over-Year 2016-2027 & (US$ Million) Figure 2. Global Adenovirus Vector Vaccine Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 3. Global Adenovirus Vector Vaccine Market Share by Regions: 2021 VS 2027 Figure 4. Global Adenovirus Vector Vaccine Forecasted Market Size Share by Region (2022-2027) Figure 5. North America Adenovirus Vector Vaccine Market Size (US$ Million) Growth Rate (2016-2027) Figure 6. Europe Adenovirus Vector Vaccine Market Size (US$ Million) and Growth Rate (2016-2027) Figure 7. Asia-Pacific Adenovirus Vector Vaccine Market Size (US$ Million) and Growth Rate (2016-2027) Figure 8. Latin America Adenovirus Vector Vaccine Market Size (US$ Million) and Growth Rate (2016-2027) Figure 9. Middle East & Africa Adenovirus Vector Vaccine Market Size (US$ Million) and Growth Rate (2016-2027) Figure 10. Global Adenovirus Vector Vaccine Market Size Share by Type in 2021 & 2027 Figure 11. Being Developed Market Size (US$ Million) YoY Growth (2016-2027) Figure 12. Preclinical Market Size (US$ Million) YoY Growth (2016-2027) Figure 13. Clinical I Market Size (US$ Million) YoY Growth (2016-2027) Figure 14. Clinical II Market Size (US$ Million) YoY Growth (2016-2027) Figure 15. Global Adenovirus Vector Vaccine Market Size Share by Application in 2021 & 2027 Figure 16. Pharmaceutical And Biotechnology Companies Market Size (US$ Million) YoY Growth (2016-2027) Figure 17. Hospital Market Size (US$ Million) YoY Growth (2016-2027) Figure 18. Academic And Research Organizations Market Size (US$ Million) YoY Growth (2016-2027) Figure 19. Other Market Size (US$ Million) YoY Growth (2016-2027) Figure 20. Adenovirus Vector Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 21. Global Top 5 and Top 10 Players Adenovirus Vector Vaccine Market Share in 2020 Figure 22. North America Adenovirus Vector Vaccine Market Share by Country (2016-2027) Figure 23. United States Adenovirus Vector Vaccine Market Size (2016-2027) & (US$ Million) Figure 24. Canada Adenovirus Vector Vaccine Market Size (2016-2027) & (US$ Million) Figure 25. Germany Adenovirus Vector Vaccine Market Size (2016-2027) & (US$ Million) Figure 26. France Adenovirus Vector Vaccine Market Size (2016-2027) & (US$ Million) Figure 27. U.K. Adenovirus Vector Vaccine Market Size (2016-2027) & (US$ Million) Figure 28. Italy Adenovirus Vector Vaccine Market Size (2016-2027) & (US$ Million) Figure 29. Russia Adenovirus Vector Vaccine Market Size (2016-2027) & (US$ Million) Figure 30. Nordic Adenovirus Vector Vaccine Market Size (2016-2027) & (US$ Million) Figure 31. Rest of Europe Adenovirus Vector Vaccine Market Size (2016-2027) & (US$ Million) Figure 32. Asia-Pacific Adenovirus Vector Vaccine Market Share by Region (2016-2027) Figure 33. China Adenovirus Vector Vaccine Market Size (2016-2027) & (US$ Million) Figure 34. Japan Adenovirus Vector Vaccine Market Size (2016-2027) & (US$ Million) Figure 35. South Korea Adenovirus Vector Vaccine Market Size (2016-2027) & (US$ Million) Figure 36. Southeast Asia Adenovirus Vector Vaccine Market Size (2016-2027) & (US$ Million) Figure 37. India Adenovirus Vector Vaccine Market Size (2016-2027) & (US$ Million) Figure 38. Australia Adenovirus Vector Vaccine Market Size (2016-2027) & (US$ Million) Figure 39. Rest of Asia-Pacific Adenovirus Vector Vaccine Market Size (2016-2027) & (US$ Million) Figure 40. Latin America Adenovirus Vector Vaccine Market Share by Country (2016-2027) Figure 41. Mexico Adenovirus Vector Vaccine Market Size (2016-2027) & (US$ Million) Figure 42. Brazil Adenovirus Vector Vaccine Market Size (2016-2027) & (US$ Million) Figure 43. Rest of Latin America Adenovirus Vector Vaccine Market Size (2016-2027) & (US$ Million) Figure 44. Middle East & Africa Adenovirus Vector Vaccine Market Share by Country (2016-2027) Figure 45. Turkey Adenovirus Vector Vaccine Market Size (2016-2027) & (US$ Million) Figure 46. Saudi Arabia Adenovirus Vector Vaccine Market Size (2016-2027) & (US$ Million) Figure 47. UAE Adenovirus Vector Vaccine Market Size (2016-2027) & (US$ Million) Figure 48. Rest of Middle East & Africa Adenovirus Vector Vaccine Market Size (2016-2027) & (US$ Million) Figure 49. Bottom-up and Top-down Approaches for This Report Figure 50. Data Triangulation

Johnson & Johnson CanSino Biologics Greffex BravoBio Altimmune